These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 37619571)

  • 41. Long-term effects of growth hormone (GH) replacement therapy on hematopoiesis in a large cohort of children with GH deficiency.
    Esposito A; Capalbo D; De Martino L; Rezzuto M; Di Mase R; Pignata C; Salerno M
    Endocrine; 2016 Jul; 53(1):192-8. PubMed ID: 26511947
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Growth Hormone Deficiency (GHD) Reversal Trial: effect on final height of discontinuation versus continuation of growth hormone treatment in pubertal children with isolated GHD-a non-inferiority Randomised Controlled Trial (RCT).
    Brettell E; Högler W; Woolley R; Cummins C; Mathers J; Oppong R; Roy L; Khan A; Hunt C; Dattani M;
    Trials; 2023 Aug; 24(1):548. PubMed ID: 37605233
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reduced microvascular perfusion and reactivity in adult GH deficient patients is restored by GH replacement.
    Hána V; Prázný M; Marek J; Skrha J; Justová V
    Eur J Endocrinol; 2002 Sep; 147(3):333-7. PubMed ID: 12213670
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Monitoring serum insulin-like growth factor-I (IGF-I), IGF binding protein-3 (IGFBP-3), IGF-I/IGFBP-3 molar ratio and leptin during growth hormone treatment for disordered growth.
    Tillmann V; Patel L; Gill MS; Whatmore AJ; Price DA; Kibirige MS; Wales JK; Clayton PE
    Clin Endocrinol (Oxf); 2000 Sep; 53(3):329-36. PubMed ID: 10971450
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Growth hormone replacement does not increase mortality in patients with childhood-onset growth hormone deficiency.
    Berglund A; Gravholt CH; Olsen MS; Christiansen JS; Stochholm K
    Clin Endocrinol (Oxf); 2015 Nov; 83(5):677-83. PubMed ID: 26147754
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of cardiac structure, exercise capacity and electrocardiography parameters in children with partial and complete growth hormone deficiency and their changes with short term growth hormone replacement therapy.
    Alkan F; Ersoy B; Kızılay DO; Ozyurt BC; Coskun S
    Pituitary; 2023 Feb; 26(1):115-123. PubMed ID: 36463549
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of growth hormone therapy on Taiwanese children with growth hormone deficiency.
    Huang YH; Wai YY; Van YH; Lo FS
    J Formos Med Assoc; 2012 Jul; 111(7):355-63. PubMed ID: 22817812
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The cardiovascular risk of adult GH deficiency (GHD) improved after GH replacement and worsened in untreated GHD: a 12-month prospective study.
    Colao A; di Somma C; Pivonello R; Cuocolo A; Spinelli L; Bonaduce D; Salvatore M; Lombardi G
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1088-93. PubMed ID: 11889170
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tissue Distribution and Receptor Activation by Somapacitan, a Long Acting Growth Hormone Derivative.
    Petersen M; Gandhi PS; Buchardt J; Alanentalo T; Fels JJ; Johansen NL; Helding-Kvist P; Vad K; Thygesen P
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32053994
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Glucose homeostasis in GHD children during long-term replacement therapy: a case-control study.
    Capalbo D; Esposito A; Improda N; Wasniewska MG; Di Mase R; De Luca F; Bruzzese D; Salerno M
    Endocrine; 2018 Mar; 59(3):643-650. PubMed ID: 28875423
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Guidance for the treatment of adult growth hormone deficiency with somapacitan, a long-acting growth hormone preparation.
    Bidlingmaier M; Biller BMK; Clemmons D; Jørgensen JOL; Nishioka H; Takahashi Y
    Front Endocrinol (Lausanne); 2022; 13():1040046. PubMed ID: 36619571
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Currently used growth-promoting treatment of children results in normal bone mass and density. A prospective trial of discontinuing growth hormone treatment in adolescents.
    Fors H; Bjarnason R; Wirént L; Albertsson-Wikland K; Bosaeust L; Bengtsson BA; Johannsson G
    Clin Endocrinol (Oxf); 2001 Nov; 55(5):617-24. PubMed ID: 11894973
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Three weekly injections (TWI) of low-dose growth hormone (GH) restore low normal circulating IGF-I concentrations and reverse cardiac abnormalities associated with adult onset GH deficiency (GHD).
    Pincelli AI; Bragato R; Scacchi M; Branzi G; Osculati G; Viarengo R; Leonetti G; Cavagnini F
    J Endocrinol Invest; 2003 May; 26(5):420-8. PubMed ID: 12906369
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of growth hormone status on body composition and the skeleton.
    Mukherjee A; Murray RD; Shalet SM
    Horm Res; 2004; 62 Suppl 3():35-41. PubMed ID: 15539797
    [TBL] [Abstract][Full Text] [Related]  

  • 55. TNF-alpha levels in children with growth hormone deficiency and the effect of long-term growth hormone replacement therapy.
    Andiran N; Yordam N
    Growth Horm IGF Res; 2007 Apr; 17(2):149-53. PubMed ID: 17314057
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Growth Responses During 3 Years of Growth Hormone Treatment in Children and Adolescents With Growth Hormone Deficiency: Comparison Between Idiopathic, Organic and Isolated Growth Hormone Deficiency, and Multiple Pituitary Hormone Deficiency.
    Lim HH; Kim YM; Lee GM; Yu J; Han HS; Yu J
    J Korean Med Sci; 2022 Mar; 37(11):e90. PubMed ID: 35315601
    [TBL] [Abstract][Full Text] [Related]  

  • 57. GH deficiency during the transition period: clinical characteristics before and after GH replacement therapy in two different subgroups of patients.
    Fideleff HL; Jonsson B; Koltowska-Häggström M; Boguszewski MC; Wilton P; Boquete HR
    J Pediatr Endocrinol Metab; 2012; 25(1-2):97-105. PubMed ID: 22570957
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Metabolomics: a tool for the diagnosis of GH deficiency and for monitoring GH replacement?
    Höybye C; Wahlström E; Tollet-Egnell P; Norstedt G
    Endocr Connect; 2014 Dec; 3(4):200-6. PubMed ID: 25312907
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Utility of P300 auditory event related potential latency in detecting cognitive dysfunction in growth hormone (GH) deficient patients with Sheehan's syndrome and effects of GH replacement therapy.
    Golgeli A; Tanriverdi F; Suer C; Gokce C; Ozesmi C; Bayram F; Kelestimur F
    Eur J Endocrinol; 2004 Feb; 150(2):153-9. PubMed ID: 14763913
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Liver fat in adults with GH deficiency: comparison to matched controls and the effect of GH replacement.
    Meienberg F; Yee M; Johnston D; Cox J; Robinson S; Bell JD; Thomas EL; Taylor-Robinson SD; Godsland I
    Clin Endocrinol (Oxf); 2016 Jul; 85(1):76-84. PubMed ID: 26895949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.